Next-generation single-use hemoperfusion devices using advanced polymeric adsorbent technology to remove endotoxins and inflammatory mediators for treatment of sepsis and multiple-organ failure in critically ill patients. Clinically validated therapy with CE mark approval under EU MDR for use in intensive care settings.